Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Infección recurrente por Clost...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Infección recurrente por Clostridium difficile tratada con bezlotoxumab

Infección recurrente por Clostridium difficile tratada con bezlotoxumab

Bibliographic Details
Main Authors: Beatriz Palenzuela Afonso, Ana B. Caparrós Nieto, Macarena González Cruz, Cristina Martínez Faci
Format: Article
Language:Spanish
Published: Elsevier 2023-02-01
Series:Anales de Pediatría
Online Access:http://www.sciencedirect.com/science/article/pii/S1695403322002223
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S1695403322002223

Similar Items

  • Recurrent Clostridium difficile infection treated with bezlotoxumab
    by: Beatriz Palenzuela Afonso, et al.
    Published: (2023-02-01)
  • Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection
    by: Navalkele BD, et al.
    Published: (2018-01-01)
  • Bezlotoxumab for the prevention of Clostridium difficile infection: a review of current evidence and safety profile
    by: Alonso CD, et al.
    Published: (2018-12-01)
  • Infección recurrente por Clostridium difficile en pediatría. Reporte de dos casos y revisión de la literatura
    by: Wilson Daza Carreño, et al.
    Published: (2016-03-01)
  • The monoclonal antitoxin antibodies (actoxumab-bezlotoxumab) treatment facilitates normalization of the gut microbiota of mice with Clostridium difficile infection
    by: Mária Džunková, et al.
    Published: (2016-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs